Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Logsdon, C. D.
Right arrow Articles by Hanash, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Logsdon, C. D.
Right arrow Articles by Hanash, S.
[Cancer Research 63, 2649-2657, May 15, 2003]
© 2003 American Association for Cancer Research

Tumor Biology

Molecular Profiling of Pancreatic Adenocarcinoma and Chronic Pancreatitis Identifies Multiple Genes Differentially Regulated in Pancreatic Cancer1

Craig D. Logsdon2, Diane M. Simeone, Charles Binkley, Thiruvengadam Arumugam, Joel K. Greenson, Thomas J. Giordano, David E. Misek and Samir Hanash

Departments of Physiology [C. D. L., T. A.], Surgery [D. M. S., C. B.], Pathology [J. K. G., T. J. G.], and Pediatric Oncology [D. E. M., R. K., S. H.], University of Michigan, Ann Arbor, Michigan 48109

The molecular basis of pancreatic cancer is not understood. Previous attempts to determine the specific genes expressed in pancreatic cancer have been hampered by similarities between adenocarcinoma and chronic pancreatitis. In the current study, microarrays (Affymetrix) were used to profile gene expression in pancreatic adenocarcinoma (10), pancreatic cancer cell lines (7), chronic pancreatitis (5), and normal pancreas (5). Molecular profiling indicated a large number of genes differentially expressed between pancreatic cancer and normal pancreas but many fewer differences between pancreatic cancer and chronic pancreatitis, likely because of the shared stromal influences in the two diseases. To specifically identify genes expressed in neoplastic epithelium, we selected genes more highly expressed (>2-fold, p < 0.01) in adenocarcinoma compared with both normal pancreas and chronic pancreatitis and which were also highly expressed in pancreatic cancer cell lines. This strategy yielded 158 genes, of which 124 were not previously associated with pancreatic cancer. Quantitative-reverse transcription-PCR for two molecules, S100P and 14-3-3{varsigma}, validated the microarray data. Support for the success of the neoplastic cell gene expression identification strategy was obtained by immunocytochemical localization of four representative genes, 14-3-3{varsigma}, S100P, S100A6, and ß4 integrin, to neoplastic cells in pancreatic tumors. Thus, comparisons between pancreatic adenocarcinoma, pancreatic cancer cell lines, normal pancreas, and chronic pancreatitis have identified genes that are selectively expressed in the neoplastic epithelium of pancreatic adenocarcinoma. These data provide new insights into the molecular pathology of pancreatic cancer that may be useful for detection, diagnosis, and treatment.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
A. Vonlaufen, P. A. Phillips, Z. Xu, D. Goldstein, R. C. Pirola, J. S. Wilson, and M. V. Apte
Pancreatic Stellate Cells and Pancreatic Cancer Cells: An Unholy Alliance
Cancer Res., October 1, 2008; 68(19): 7707 - 7710.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Ramachandran, T. Arumugam, H. Wang, and C. D. Logsdon
Anterior Gradient 2 Is Expressed and Secreted during the Development of Pancreatic Cancer and Promotes Cancer Cell Survival
Cancer Res., October 1, 2008; 68(19): 7811 - 7818.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. M. A. Moreira, T. Shen, G. Ohlsson, P. Gromov, I. Gromova, and J. E. Celis
A Combined Proteome and Ultrastructural Localization Analysis of 14-3-3 Proteins in Transformed Human Amnion (AMA) Cells: Definition of A Framework to Study Isoform-Specific Differences
Mol. Cell. Proteomics, July 1, 2008; 7(7): 1225 - 1240.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
T Qi, J Han, Y Cui, M Zong, X Liu, and B Zhu
Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas
J. Clin. Pathol., January 1, 2008; 61(1): 49 - 58.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Li, Y. Zhang, Z. Liu, U. Bharadwaj, H. Wang, X. Wang, S. Zhang, J. P. Liuzzi, S.-M. Chang, R. J. Cousins, et al.
Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression
PNAS, November 20, 2007; 104(47): 18636 - 18641.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S.-O. Lee, Y.-C. Chang, K. Whang, C.-H. Kim, and I.-S. Lee
Role of NAD(P)H:quinone oxidoreductase 1 on tumor necrosis factor-{alpha}-induced migration of human vascular smooth muscle cells
Cardiovasc Res, November 1, 2007; 76(2): 331 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
O. M. Tsygankova, G. V. Prendergast, K. Puttaswamy, Y. Wang, M. D. Feldman, H. Wang, M. S. Brose, and J. L. Meinkoth
Downregulation of Rap1GAP Contributes to Ras Transformation
Mol. Cell. Biol., October 1, 2007; 27(19): 6647 - 6658.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
B. Goulet, L. Sansregret, L. Leduy, M. Bogyo, E. Weber, S. S. Chauhan, and A. Nepveu
Increased Expression and Activity of Nuclear Cathepsin L in Cancer Cells Suggests a Novel Mechanism of Cell Transformation
Mol. Cancer Res., September 1, 2007; 5(9): 899 - 907.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
R. Chen, T. A. Brentnall, S. Pan, K. Cooke, K. W. Moyes, Z. Lane, D. A. Crispin, D. R. Goodlett, R. Aebersold, and M. P. Bronner
Quantitative Proteomics Analysis Reveals That Proteins Differentially Expressed in Chronic Pancreatitis Are Also Frequently Involved in Pancreatic Cancer
Mol. Cell. Proteomics, August 1, 2007; 6(8): 1331 - 1342.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
K. Ohuchida, K. Mizumoto, J. Yu, H. Yamaguchi, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
S100A6 Is Increased in a Stepwise Manner during Pancreatic Carcinogenesis: Clinical Value of Expression Analysis in 98 Pancreatic Juice Samples
Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 649 - 654.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Ramachandran, T. Arumugam, R. F. Hwang, J. K. Greenson, D. M. Simeone, and C. D. Logsdon
Adrenomedullin Is Expressed in Pancreatic Cancer and Stimulates Cell Proliferation and Invasion in an Autocrine Manner via the Adrenomedullin Receptor, ADMR
Cancer Res., March 15, 2007; 67(6): 2666 - 2675.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Li, D. G. Heidt, P. Dalerba, C. F. Burant, L. Zhang, V. Adsay, M. Wicha, M. F. Clarke, and D. M. Simeone
Identification of Pancreatic Cancer Stem Cells
Cancer Res., February 1, 2007; 67(3): 1030 - 1037.
[Abstract] [Full Text] [PDF]

Home page
 Biophys. JHome page
M. H. Zaman
Understanding the Molecular Basis for Differential Binding of Integrins to Collagen and Gelatin
Biophys. J., January 15, 2007; 92(2): L17 - L19.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
T. Fukazawa, Y. Maeda, M. L. Durbin, T. Nakai, J. Matsuoka, H. Tanaka, Y. Naomoto, and N. Tanaka
Pulmonary adenocarcinoma-targeted gene therapy by a cancer- and tissue-specific promoter system
Mol. Cancer Ther., January 1, 2007; 6(1): 244 - 252.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
T. Arumugam, V. Ramachandran, and C. D. Logsdon
Effect of Cromolyn on S100P Interactions With RAGE and Pancreatic Cancer Growth and Invasion in Mouse Models
J Natl Cancer Inst, December 20, 2006; 98(24): 1806 - 1818.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
R. Hwang and D. Evans
Cancer Antigens 19-9 and 125 in the Differential Diagnosis of Pancreatic Mass Lesions--Invited Critique
Arch Surg, October 1, 2006; 141(10): 974 - 974.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Ohuchida, K. Mizumoto, T. Egami, H. Yamaguchi, K. Fujii, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
S100P Is an Early Developmental Marker of Pancreatic Carcinogenesis.
Clin. Cancer Res., September 15, 2006; 12(18): 5411 - 5416.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. S. Ahn, G. Sethi, A. K. Jain, A. K. Jaiswal, and B. B. Aggarwal
Genetic Deletion of NAD(P)H:Quinone Oxidoreductase 1 Abrogates Activation of Nuclear Factor-{kappa}B, I{kappa}B{alpha} Kinase, c-Jun N-terminal Kinase, Akt, p38, and p44/42 Mitogen-activated Protein Kinases and Potentiates Apoptosis
J. Biol. Chem., July 21, 2006; 281(29): 19798 - 19808.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
D. L. Dehn, D. Siegel, K. S. Zafar, P. Reigan, E. Swann, C. J. Moody, and D. Ross
5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
Mol. Cancer Ther., July 1, 2006; 5(7): 1702 - 1709.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Deng, D. Z. Ewton, S. Li, A. Naqvi, S. E. Mercer, S. Landas, and E. Friedman
The Kinase Mirk/Dyrk1B Mediates Cell Survival in Pancreatic Ductal Adenocarcinoma.
Cancer Res., April 15, 2006; 66(8): 4149 - 4158.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Liu, H. Liu, B. Han, and J.-T. Zhang
Identification of 14-3-3{sigma} as a Contributor to Drug Resistance in Human Breast Cancer Cells Using Functional Proteomic Analysis.
Cancer Res., March 15, 2006; 66(6): 3248 - 3255.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
H. Sawai, J. Liu, H. A. Reber, O. J. Hines, and G. Eibl
Activation of Peroxisome Proliferator-Activated Receptor-{gamma} Decreases Pancreatic Cancer Cell Invasion through Modulation of the Plasminogen Activator System
Mol. Cancer Res., March 1, 2006; 4(3): 159 - 167.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Zhang, L. Chenwei, R. Mahmood, K. v. Golen, J. Greenson, G. Li, N. J. D'Silva, X. Li, C. F. Burant, C. D. Logsdon, et al.
Identification of a Putative Tumor Suppressor Gene Rap1GAP in Pancreatic Cancer
Cancer Res., January 15, 2006; 66(2): 898 - 906.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Wang, A. Platt-Higgins, J. Carroll, S. de Silva Rudland, J. Winstanley, R. Barraclough, and P. S. Rudland
Induction of Metastasis by S100P in a Rat Mammary Model and Its Association with Poor Survival of Breast Cancer Patients
Cancer Res., January 15, 2006; 66(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Matsubayashi, M. Canto, N. Sato, A. Klein, T. Abe, K. Yamashita, C. J. Yeo, A. Kalloo, R. Hruban, and M. Goggins
DNA Methylation Alterations in the Pancreatic Juice of Patients with Suspected Pancreatic Disease
Cancer Res., January 15, 2006; 66(2): 1208 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. L. Ramirez, R. Rosell, M. Taron, M. Sanchez-Ronco, V. Alberola, R. de las Penas, J. M. Sanchez, T. Moran, C. Camps, B. Massuti, et al.
14-3-3{sigma} Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non-Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group
J. Clin. Oncol., December 20, 2005; 23(36): 9105 - 9112.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K. Ohuchida, K. Mizumoto, N. Ishikawa, K. Fujii, H. Konomi, E. Nagai, K. Yamaguchi, M. Tsuneyoshi, and M. Tanaka
The Role of S100A6 in Pancreatic Cancer Development and Its Clinical Implication as a Diagnostic Marker and Therapeutic Target
Clin. Cancer Res., November 1, 2005; 11(21): 7785 - 7793.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Arumugam, D. M. Simeone, K. Van Golen, and C. D. Logsdon
S100P Promotes Pancreatic Cancer Growth, Survival, and Invasion
Clin. Cancer Res., August 1, 2005; 11(15): 5356 - 5364.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. Goggins
Molecular Markers of Early Pancreatic Cancer
J. Clin. Oncol., July 10, 2005; 23(20): 4524 - 4531.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Qian, J. Niu, M. Li, P. J. Chiao, and M.-S. Tsao
In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K-ras Oncogenic Activation in Pancreatic Carcinogenesis
Cancer Res., June 15, 2005; 65(12): 5045 - 5053.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
B. Gleason, B. Adley, M. S. Rao, and L. K. Diaz
Immunohistochemical Detection of the {beta}4 Integrin Subunit in Pancreatic Adenocarcinoma
J. Histochem. Cytochem., June 1, 2005; 53(6): 799 - 801.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Segara, A. V. Biankin, J. G. Kench, C. C. Langusch, A. C. Dawson, D. A. Skalicky, D. C. Gotley, M. J. Coleman, R. L. Sutherland, and S. M. Henshall
Expression of HOXB2, a Retinoic Acid Signaling Target in Pancreatic Cancer and Pancreatic Intraepithelial Neoplasia
Clin. Cancer Res., May 1, 2005; 11(9): 3587 - 3596.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Vimalachandran, W. Greenhalf, C. Thompson, J. Luttges, W. Prime, F. Campbell, A. Dodson, R. Watson, T. Crnogorac-Jurcevic, N. Lemoine, et al.
High Nuclear S100A6 (Calcyclin) Is Significantly Associated with Poor Survival in Pancreatic Cancer Patients
Cancer Res., April 15, 2005; 65(8): 3218 - 3225.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Gesierich, C. Paret, D. Hildebrand, J. Weitz, K. Zgraggen, F. H. Schmitz-Winnenthal, V. Horejsi, O. Yoshie, D. Herlyn, L. K. Ashman, et al.
Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
Clin. Cancer Res., April 15, 2005; 11(8): 2840 - 2852.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis
Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast
Mol. Cell. Proteomics, April 1, 2005; 4(4): 555 - 569.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
R. Chen, S. Pan, T. A. Brentnall, and R. Aebersold
Proteomic Profiling of Pancreatic Cancer for Biomarker Discovery
Mol. Cell. Proteomics, April 1, 2005; 4(4): 523 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. B. Prasad, A. V. Biankin, N. Fukushima, A. Maitra, S. Dhara, A. G. Elkahloun, R. H. Hruban, M. Goggins, and S. D. Leach
Gene Expression Profiles in Pancreatic Intraepithelial Neoplasia Reflect the Effects of Hedgehog Signaling on Pancreatic Ductal Epithelial Cells
Cancer Res., March 1, 2005; 65(5): 1619 - 1626.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. E. Dowen, T. Crnogorac-Jurcevic, R. Gangeswaran, M. Hansen, J. J. Eloranta, V. Bhakta, T. A. Brentnall, J. Luttges, G. Kloppel, and N. R. Lemoine
Expression of S100P and Its Novel Binding Partner S100PBPR in Early Pancreatic Cancer
Am. J. Pathol., January 1, 2005; 166(1): 81 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Shen, M. D. Person, J. Zhu, J. L. Abbruzzese, and D. Li
Protein Expression Profiles in Pancreatic Adenocarcinoma Compared with Normal Pancreatic Tissue and Tissue Affected by Pancreatitis as Detected by Two-Dimensional Gel Electrophoresis and Mass Spectrometry
Cancer Res., December 15, 2004; 64(24): 9018 - 9026.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Li, M. A. R. St. John, X. Zhou, Y. Kim, U. Sinha, R. C. K. Jordan, D. Eisele, E. Abemayor, D. Elashoff, N.-H. Park, et al.
Salivary Transcriptome Diagnostics for Oral Cancer Detection
Clin. Cancer Res., December 15, 2004; 10(24): 8442 - 8450.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
A. Guweidhi, J. Kleeff, N. Giese, J. E. Fitori, K. Ketterer, T. Giese, M. W. Buchler, M. Korc, and H. Friess
Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis
Carcinogenesis, September 1, 2004; 25(9): 1575 - 1585.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Lewis, M. Ough, L. Li, M. M. Hinkhouse, J. M. Ritchie, D. R. Spitz, and J. J. Cullen
Treatment of Pancreatic Cancer Cells with Dicumarol Induces Cytotoxicity and Oxidative Stress
Clin. Cancer Res., July 1, 2004; 10(13): 4550 - 4558.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. E. Jones, M. J. Humphreys, F. Campbell, J. P. Neoptolemos, and M. T. Boyd
Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer: Increased Expression of Matrix Metalloproteinase-7 Predicts Poor Survival
Clin. Cancer Res., April 15, 2004; 10(8): 2832 - 2845.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. ProteomicsHome page
J. M. A. Moreira, P. Gromov, and J. E. Celis
Expression of the Tumor Suppressor Protein 14-3-3{sigma} Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition
Mol. Cell. Proteomics, April 1, 2004; 3(4): 410 - 419.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Sato, N. Fukushima, A. Maitra, C. A. Iacobuzio-Donahue, N. T. van Heek, J. L. Cameron, C. J. Yeo, R. H. Hruban, and M. Goggins
Gene Expression Profiling Identifies Genes Associated with Invasive Intraductal Papillary Mucinous Neoplasms of the Pancreas
Am. J. Pathol., March 1, 2004; 164(3): 903 - 914.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Arumugam, D. M. Simeone, A. M. Schmidt, and C. D. Logsdon
S100P Stimulates Cell Proliferation and Survival via Receptor for Activated Glycation End Products (RAGE)
J. Biol. Chem., February 13, 2004; 279(7): 5059 - 5065.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
R. D. Irwin, G. A. Boorman, M. L. Cunningham, A. N. Heinloth, D. E. Malarkey, and R. S. Paules
Application of Toxicogenomics to Toxicology: Basic Concepts in the Analysis of Microarray Data
Toxicol Pathol, January 1, 2004; 32(1_suppl): 72 - 83.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
J. J. Cullen, M. M. Hinkhouse, M. Grady, A. W. Gaut, J. Liu, Y. P. Zhang, C. J. Darby Weydert, F. E. Domann, and L. W. Oberley
Dicumarol Inhibition of NADPH:Quinone Oxidoreductase Induces Growth Inhibition of Pancreatic Cancer via a Superoxide-mediated Mechanism
Cancer Res., September 1, 2003; 63(17): 5513 - 5520.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.